Skip to main content
Fig. 7 | Journal of Nanobiotechnology

Fig. 7

From: Attenuation of inflammatory bowel disease by oral administration of mucoadhesive polydopamine-coated yeast β-glucan via ROS scavenging and gut microbiota regulation

Fig. 7

Colitis alleviation effect of YBNs@PDA in a delayed therapeutic setting. (A) Experimental timeline for different treatments. (B) Daily bodyweight changes in each group. YBNs (10 mg/kg) or YBNs@PDA (L: low dose: 5 mg/kg; H: High dose: 10 mg/kg). (C) Macroscopic colon appearance of each group. (D) Colon length was determined in the indicated groups. (E) Representative hematoxylin and eosin (H&E) staining images, alcian blue images, colonic MPO and Tunel images of colon tissue of each group, respectively. Data are presented as mean ± standard deviation from a representative experiment (n = 6). *P < 0.05, analysed by two-tailed unpaired Student’s t-test (D)

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us